April 6, 2022
Medwatcher Japan, a citizen’s drug damage watchdog, said on April 5 that it has submitted a request to the health ministry and MSD to temporarily suspend the use of the company’s oral COVID-19 treatment Lagevrio (molnupiravir) due to safety concerns...read more